cbdMD, Inc. to Host Conference Call to Discuss June 30, 2025, Third Quarter of Fiscal Year 2025 Results
cbdMD (NYSE American: YCBD), a leading CBD company, has scheduled a conference call to discuss its Q3 FY2025 financial results for the period ending June 30, 2025. The call will take place on Thursday, August 14, 2025, at 4:20 p.m. Eastern Time.
Investors can access the call through multiple channels including USA/Canada (833-821-3524) and International (647-846-2919) dial-in numbers. A replay will be available with passcode 5327882, and the webcast replay will remain accessible through August 15, 2026, via the provided link.
cbdMD (NYSE American: YCBD), azienda leader nel settore del CBD, ha programmato una conference call per illustrare i risultati finanziari del terzo trimestre dell'esercizio 2025 (Q3 FY2025) relativi al periodo chiuso il 30 giugno 2025. La call si terr脿 gioved矛 14 agosto 2025 alle 16:20, ora orientale.
Gli investitori potranno partecipare tramite vari canali, inclusi i numeri per USA/Canada (833-821-3524) e per l'estero (647-846-2919). Sar脿 disponibile una registrazione con codice di accesso 5327882 e la riproduzione via webcast rester脿 accessibile fino al 15 agosto 2026 tramite il link fornito.
cbdMD (NYSE American: YCBD), una empresa l铆der en CBD, ha programado una conferencia telef贸nica para comentar sus resultados financieros del tercer trimestre del ejercicio 2025 (Q3 FY2025) correspondientes al periodo finalizado el 30 de junio de 2025. La llamada se realizar谩 el jueves 14 de agosto de 2025 a las 4:20 p.m., hora del Este.
Los inversores podr谩n acceder a la llamada por varios canales, incluidos los n煤meros para EE.聽UU./Canad谩 (833-821-3524) e Internacional (647-846-2919). Habr谩 una repetici贸n disponible con c贸digo de acceso 5327882, y la retransmisi贸n por webcast permanecer谩 accesible hasta el 15 de agosto de 2026 mediante el enlace proporcionado.
cbdMD (NYSE American: YCBD)電� 靹犽弰鞝侅澑 CBD 旮办梾鞙茧, 2025 須岅硠鞐半弰 3攵勱赴(Q3 FY2025) 鞁れ爜(旮瓣皠 膦呺鞚�: 2025雲� 6鞗� 30鞚�)鞚� 氚滍憸頃橁赴 鞙勴暅 旎嵓霟办姢 旖滌潉 鞓堨爼頄堨姷雼堧嫟. 韱淀檾電� 2025雲� 8鞗� 14鞚� 氇╈殧鞚� 氙戈淡 霃欕秬 鞁滉皠 旮办 鞓ろ泟 4鞁� 20攵勳棎 歆勴枆霅╇媹雼�.
韴瀽鞛愲摛鞚� 氙戈淡/旌愲倶雼�(833-821-3524) 氚� 甑牅(647-846-2919) 鞝勴檾氩堩樃 霌� 雼れ枒頃� 毂勲剱鞚� 韱淀暣 彀胳棳頃� 靾� 鞛堨姷雼堧嫟. 鞛箔旆姅 鞝戩啀 旖旊摐 5327882搿� 鞚挫毄 臧�電ロ晿氅�, 鞗轨簮鞀ろ姼 鞛儩鞚� 鞝滉车霅� 毵來伂毳� 韱淀暣 2026雲� 8鞗� 15鞚缄箤歆� 頇曥澑頃橃嫟 靾� 鞛堨姷雼堧嫟.
cbdMD (NYSE American: YCBD), entreprise leader dans le CBD, a programm茅 une conf茅rence t茅l茅phonique pour pr茅senter ses r茅sultats financiers du troisi猫me trimestre de l'exercice 2025 (Q3 FY2025) pour la p茅riode close le 30 juin 2025. L'appel aura lieu le jeudi 14 ao没t 2025 脿 16h20, heure de l'Est.
Les investisseurs pourront acc茅der 脿 l'appel via plusieurs canaux, notamment les num茅ros pour 脡tats-Unis/Canada (833-821-3524) et International (647-846-2919). Une rediffusion sera disponible avec le code d'acc猫s 5327882, et la lecture du webcast restera accessible jusqu'au 15 ao没t 2026 via le lien fourni.
cbdMD (NYSE American: YCBD), ein f眉hrendes CBD-Unternehmen, hat eine Telefonkonferenz angesetzt, um die Finanzergebnisse des dritten Quartals des Gesch盲ftsjahres 2025 (Q3 FY2025) f眉r den zum 30. Juni 2025 endenden Zeitraum zu besprechen. Die Konferenz findet am Donnerstag, den 14. August 2025, um 16:20 Uhr Eastern Time statt.
Investoren k枚nnen 眉ber verschiedene Kan盲le teilnehmen, unter anderem 眉ber die Einwahlnummern f眉r USA/Kanada (833-821-3524) und International (647-846-2919). Eine Aufzeichnung ist mit dem Zugangscode 5327882 verf眉gbar, und das Webcast-Replay bleibt 眉ber den bereitgestellten Link bis zum 15. August 2026 zug盲nglich.
- None.
- None.
Charlotte, North Carolina--(Newsfile Corp. - August 12, 2025) - cbdMD, Inc. (NYSE American: YCBD), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Thursday, August 14, 2025, to discuss the company's June 30, 2025 third quarter of fiscal year 2025 financial results and business progress.
CONFERENCE CALL DETAILS
| Thursday, August 14, 2025, 4:20 p.m. Eastern Time | |
| USA/Canada: | 833-821-3524 |
| International: | 647-846-2919 |
| Teleconference Replay dial in: | |
| USA/Canada: | 855-669-9658 |
| International: | 412-317-0088 |
| Replay Passcode: | 5327882 |
| Webcast/Webcast Replay link - available through August 15, 2026 | |
About cbdMD, Inc.
cbdMD, Inc. (NYSE American: YCBD) is one of the leading and most highly trusted and most recognized cannabidiol (CBD) brands with a comprehensive line of U.S. produced THC-free1 CBD products and an array of Farm Act compliant Delta 9 products. Our Paw CBD brand of pet products includes veterinarian-formulated products and our ATRx brand features functional mushroom products. In addition, we operate Herbal Oasis, a premium, award winning THC-infused social seltzer that blends cannabinoids and nootropic mushrooms to deliver a fast-acting, functional beverage made for presence and connection. With an alcohol-free formula and wellness-forward ingredients, Oasis invites a better way to drink-one rooted in clarity, balance, and joy. To learn more about cbdMD and our comprehensive line of U.S. grown, THC-free1 CBD and Full Spectrum products as well as our other brands, please visit , , , or , follow cbdMD on Instagram and Facebook, or visit one of the thousands of retail outlets that carry cbdMD's products.
(1) THC-free is defined as below the level of detection using validated scientific analytical methods.
Contact Information:
cbdMD, Inc.
Ronan Kennedy, CEO and CFO
Phone: +1 (704) 445-3064
email: [email protected]
To view the source version of this press release, please visit
FAQ
When is cbdMD's Q3 2025 earnings call scheduled?
How can investors access cbdMD's Q3 2025 earnings call?
How long will cbdMD's Q3 2025 earnings call replay be available?
What period will cbdMD's earnings call cover?
